top of page
0B9A0963.jpg

Epithelial 

(dys)function

0B9A1115 klein.jpg

Tissue damage

Epithelial Remodeling

We use primary epithelial cell cultures for studies on airway epithelial remodeling in COPD, ILD and lung cancer.

IMG-20210520-WA0005_edited.jpg
0B9A1428_edited.jpg
2132519863_edited.png
wit.jpg
wit.jpg
organoid 2 rand.jpg

Tissue damage

Pulmonary fibrosis

We use Organoid and Transwell cultures to investigate the biology of radiation-induced lung fibrosis.

Merian website.png
Annelies-Slats website.jpg
0B9A1451_edited.jpg
Padmini_edited.jpg
wit.jpg
0B9A1004 klein.jpg

Tissue damage

COVID-19 lung damage

We use primary alveolar cell cultures and organoid technology in combination with the Lung-Chip to develop a human cell culture model of COVID-19-related lung damage.

Annemarie
0B9A1428_edited.jpg
0B9A1470.jpg
wit.jpg
wit.jpg
ELISAplaat.jpg

Tissue damage

AATD Biomarkers

We assess biomarkers to study effects of AAT therapy in patients with Alpha-1 Antitrypsin-related emphysema.

Foto website Naomi Kappe_edited.jpg
Jan-Stolk-website_edited.jpg
2b6d2053-76c5-459f-9d8d-341b8a2373d0%252
wit.jpg
wit.jpg
0B9A1424 klein.jpg

Regeneration

MSC therapy

Using a variety of technologies, we study emphysematous lung tissue obtained before and after mesenchymal stem cell (MSC) therapy to identify markers of repair and/or altered immune responses.

Padmini_edited.jpg
Annemarie
Jan-Stolk-website_edited.jpg
wit.jpg
wit.jpg
0B9A0926.jpg

Lung cancer

Tumor Recurrence

Using Organoid and Lung-Chip technology, we study NSCLC tumor characteristics to identify patients at risk for recurrence.

0B9A1428_edited.jpg
Annemarie
wit.jpg
wit.jpg
wit.jpg
bottom of page